Eric Green - West Pharmaceutical President, Chief Executive Officer, Director
| WST Stock | USD 390.20 14.85 3.96% |
CEO
Mr. Eric Mark Green is President, Chief Executive Officer, Director of the West Pharmaceutical Services, Inc. Mr. Green was our President and Chief Executive Officer since April 2015 and a member of our Board of Directors since May 2015. Mr. Green is responsible for leading West marketled business strategy, focused on tailoring our approach to the specific needs of Biologics, Generics, Pharmaceutical and Diagnostic customer groups. Prior to joining the Company, Mr. Green worked at SigmaAldrich Corporationrationrationa leading life science and technology company focused on human health and safetywhere he served as Executive Vice President and President of their Research Markets business unit since 2013. Mr. Green also serves as a member of Bethel University Board of Trustees. since 2015.
| Age | 54 |
| Tenure | 9 years |
| Address | 530 Herman O. West Drive, Exton, PA, United States, 19341-1147 |
| Phone | 610 594 2900 |
| Web | https://www.westpharma.com |
Eric Green Latest Insider Activity
Tracking and analyzing the buying and selling activities of Eric Green against West Pharmaceutical stock is an integral part of due diligence when investing in West Pharmaceutical. Eric Green insider activity provides valuable insight into whether West Pharmaceutical is net buyers or sellers over its current business cycle. Note, West Pharmaceutical insiders must abide by specific rules, including filing SEC forms every time they buy or sell West Pharmaceutical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Eric Green over three weeks ago Disposition of 64132 shares by Eric Green of West Pharmaceutical at 359.8511 subject to Rule 16b-3 |
West Pharmaceutical Management Efficiency
The company has Return on Asset of 0.1193 % which means that on every $100 spent on assets, it made $0.1193 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2132 %, implying that it generated $0.2132 on every 100 dollars invested. West Pharmaceutical's management efficiency ratios could be used to measure how well West Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.17 in 2024. Return On Capital Employed is likely to gain to 0.22 in 2024. At this time, West Pharmaceutical's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 4 B in 2024, despite the fact that Change To Liabilities is likely to grow to (3.1 M).Similar Executives
| Found 4 records | CEO Age | ||
| Lennart Flem | National Research Corp | N/A | |
| Jon Kessler | HealthEquity | 56 | |
| Oivind Horpestad | National Research Corp | N/A | |
| Michael Hays | National Research Corp | 69 | |
Management Performance
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.12 |
West Pharmaceutical Leadership Team
Elected by the shareholders, the West Pharmaceutical's board of directors comprises two types of representatives: West Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of West. The board's role is to monitor West Pharmaceutical's management team and ensure that shareholders' interests are well served. West Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, West Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Buthman, Independent Director | ||
| Deborah Tanner, Independent Director | ||
| Bernard Birkett, Chief Financial Officer, Senior Vice President, Principal Accounting Officer, Treasurer | ||
| Eric Green, President, Chief Executive Officer, Director | ||
| John Weiland, Independent Director | ||
| William Federici, CFO and Sr. VP | ||
| Rudy Poussot, Senior Development | ||
| Michael Anderson, Vice President Treasurer | ||
| Dr CFA, Vice Relations | ||
| William Feehery, Independent Director | ||
| Robert Friel, Independent Director | ||
| Richard Luzzi, VP HR | ||
| Daniel Malone, Principal Accounting Officer, VP and Controller | ||
| Myla LaiGoldman, Independent Director | ||
| Heino Lennartz, President - Pharmaceutical Packaging Systems Europe Region | ||
| Paula Johnson, Independent Director | ||
| Douglas Michels, Independent Director | ||
| Michele Polinsky, Vice Communications | ||
| Kimberly MacKay, Senior Vice President General Counsel, Corporate Secretary | ||
| Karen Flynn, Senior Vice President and Chief Commercial Officer | ||
| Paolo Pucci, Independent Director | ||
| Annette Favorite, Chief Human Resource Officer, Senior Vice President | ||
| Anthony Welters, Independent Director | ||
| Patrick Zenner, Independent Chairman of the Board | ||
| Thomas Hofmann, Independent Director | ||
| Silji Abraham, Senior Vice President and Chief Digital and Transformation Officer | ||
| David Montecalvo, Senior Vice President, Chief Operating and Supply Chain Officer | ||
| John Paproski, CTO and Sr. VP | ||
| Christopher Ryan, Senior Vice President of Commercial Products and Emerging Markets | ||
| Warwick Bedwell, President of Pharmaceutical Packaging Systems Asia-Pacific Region | ||
| Quintin Lai, Vice President - Corporate Development, Strategy and Investor Relations | ||
| Molly Joseph, Director | ||
| George Miller, Senior Vice President General Counsel, Corporate Secretary | ||
| Cindy ReissClark, Senior Vice President of Global Market Units and Commercial Solutions | ||
| Chad Winters, Chief Accounting Officer, Principal Accounting Officer, Vice President, Corporate Controller | ||
| Robert Segura, VP Devel | ||
| Eric Resnick, Chief Technology Officer, Vice President |
West Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is West Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 26.97 B | ||||
| Shares Outstanding | 73.21 M | ||||
| Shares Owned By Insiders | 0.56 % | ||||
| Shares Owned By Institutions | 95.90 % | ||||
| Number Of Shares Shorted | 1.13 M | ||||
| Price To Earning | 40.71 X |
West Pharmaceutical Investors Sentiment
The influence of West Pharmaceutical's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in West. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to West Pharmaceutical's public news can be used to forecast risks associated with an investment in West. The trend in average sentiment can be used to explain how an investor holding West can time the market purely based on public headlines and social activities around West Pharmaceutical Services. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
West Pharmaceutical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for West Pharmaceutical's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average West Pharmaceutical's news discussions. The higher the estimated score, the more favorable is the investor's outlook on West Pharmaceutical.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards West Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, West Pharmaceutical's short interest history, or implied volatility extrapolated from West Pharmaceutical options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether West Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if West Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about West Pharmaceutical Services Stock. Highlighted below are key reports to facilitate an investment decision about West Pharmaceutical Services Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for West Stock analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is West Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of West Pharmaceutical. If investors know West will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.334 | Dividend Share 0.77 | Earnings Share 7.88 | Revenue Per Share 39.701 | Quarterly Revenue Growth 0.033 |
The market value of West Pharmaceutical is measured differently than its book value, which is the value of West that is recorded on the company's balance sheet. Investors also form their own opinion of West Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is West Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because West Pharmaceutical's market value can be influenced by many factors that don't directly affect West Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, West Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.